In April 2022, following the annual ESSKA congress, a group of experts published an important document stating their recommendations on the use of PRP in the management of knee osteoarthritis. This is a consensus paper which was obtained after more than 2 years of deliberations on the subject, answering 28 specific questions for which an… Continue reading ORthoBIologics InitiaTive (ORBIT) Consensus from ESSKA
In April 2022, following the annual ESSKA congress, a group of experts published an important document stating their recommendations on the use of PRP in the management of knee osteoarthritis.
This is a consensus paper which was obtained after more than 2 years of deliberations on the subject, answering 28 specific questions for which an exhaustive review of the literature was conducted and noted by the steering group of 12 experts from 9 different countries. Literature ranging from Grade A (high level of evidence) to Grade D (Expert opinions) were considered.
The questions are divided into 3 sections:
Section 1: PRP Rationale/Indications (Question 1-14)
Section 2: PRP Preparation/Characterization (Question 15-18)
Section 3: PRP Protocol (Question 19-28)
Grading description
| Grade A | High Scientific Level |
| Grade B | Scientific Presumption |
| Grade C | Low Scientific Level |
| Grade D | Expert Opinion |
These proposals have been submitted to another group of 22 experts (rating group) to validate the recommendations (rating from 1 to 9 -> 9 being a total agreement with the recommendation)
Consult Q&A of Section 1: PRP Rationale/Indications (Question 1-14)
RegenLab’s Scientific team
Sources :